Roger S. Kirby – författare

The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease.

Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents.

Derived from the benchmark title on BPH -Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.

Since its first edition, Men''s Health has established itself as the essential reference for practitioners across the spectrum of medicine - including those working in urology, andrology, cardiology, endocrinology, family practice and mental health. For this fully updated fourth edition the editors have again assembled an international team of expert authors to write on an encyclopedic range of topics, making this an invaluable resource for any health professional interested in maintaining and improving the health of their male patients.

Since its first edition, Men''s Health has established itself as the essential reference for practitioners across the spectrum of medicine - including those working in urology, andrology, cardiology, endocrinology, family practice and mental health. For this fully updated fourth edition the editors have again assembled an international team of expert authors to write on an encyclopedic range of topics, making this an invaluable resource for any health professional interested in maintaining and improving the health of their male patients.

The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease.

Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents.

Derived from the benchmark title on BPH -Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.

Great strides have been made in the understanding of the scientific basis of urological conditions and this has allowed the development of drugs for a wide variety of urological disorders.

This book provides urologists with a working guide to the rapidly growing armoury of drugs available to them.

The ABC of Prostate Cancer provides fully illustrated guidance on the treatment and management of prostate cancer. It covers the biology, anatomy, and pathology of prostate cancer, screening, and active surveillance and monitoring. It presents an assessment of treatment options including prostatectomy, bracytherapy, chemotherapy and immunotherapy, along with modern diagnostic tests and an overview of new approaches to prostate cancer.

With an international author team, the ABC of Prostate Cancer is ideal for general practitioners, family physicians, specialist nurses, junior doctors, medical students and others working with prostate cancer patients and their families.

The ABC of Prostate Cancer provides fully illustrated guidance on the treatment and management of prostate cancer. It covers the biology, anatomy, and pathology of prostate cancer, screening, and active surveillance and monitoring. It presents an assessment of treatment options including prostatectomy, bracytherapy, chemotherapy and immunotherapy, along with modern diagnostic tests and an overview of new approaches to prostate cancer.

With an international author team, the ABC of Prostate Cancer is ideal for general practitioners, family physicians, specialist nurses, junior doctors, medical students and others working with prostate cancer patients and their families.